Basf Se · XETR:BAS
Basf — Investor Day (September 2024)
17 slides from Basf's investor day presentation, Sep 27, 2024
Slide 1: Nutrition & Care
Nutrition & Care Michael Heinz Member of the Board of Executive Directors BASF Capital Markets Day, September 2024
Slide 2: Cautionary note regarding forward-looking statements
Cautionary note regarding forward-looking statements This presentation contains forward-looking statements. These statements are based on current estimates and projections of the Board of Executive Directors and currently available information. Forward-looking statements are not guarantees of the fu
Slide 3: Nutrition & Care
Nutrition & Care Leading provider of essential ingredients and innovative products dedicated towards improving the quality of life ~€7.0 billion sales in 2023 (share of industries in %) Nutrition & Health Care Chemicals Nutrition Aroma Pharma Personal Care Home Care and I&I1 Ind. Formulators 14% 7%
Slide 4: Nutrition & Care will keep its leading market segment positions
Nutrition & Care will keep its leading market segment positions Market BASF Segment Growth1 Main peers Sales Portfolio Key products Position2 NHU, ZMC, Vitamins, carotenoids Vitamin A, Nutrition ~3% DSM-F3, Adisseo €1.0bn enzymes vitamin E #1-4 NHU, Symrise, Menthol, fragrance Synthetic menthol, Aro
Slide 5: Verbund integration ensures competitive cost and sustainability advantages
Verbund integration ensures competitive cost and sustainability advantages as well as feedstock and material flow flexibility Superior cost position through material and energy integration into world-scale upstream assets Interconnection reduces logistics costs Sustainability leverage via ener
Slide 6: BASF technologies and assets are highly competitive globally
BASF technologies and assets are highly competitive globally Citral Vitamin A acetate Cash cost 2024 Cash cost 2024 Cash cost Cash cost BASF sites Competitors BASF site Competitors Kuantan Ludwigshafen Ludwigshafen Production capacity Production capacity Competitive advantages Kuantan, Ludwigshafen
Slide 7: Nutrition & Care invested heavily into the future and will deliver solid earnings growth
Nutrition & Care invested heavily into the future and will deliver solid earnings growth Key investments 2021 / 2024 2023 2025 / 2026 2026 Vitamin A NIS1 plant APG2 Aroma & NIS1 Ludwigshafen Antwerp Asia, Zhanjiang, EBITDA bsi North America Ludwigshafen Capex EBITDA bsi > Capex 2004 2006 2008 2010 2
Slide 8: Nutrition & Care will significantly increase earnings by 2028
Nutrition & Care will significantly increase earnings by 2028 despite a challenging market environment Sales EBITDA bsi 2019 – 2023 Target 2028 Billion € Billion € €6.7 billion €8.7 billion Ø Sales p.a. Sales 15% 17% Ø EBITDA bsi margin EBITDA bsi margin €1.0 billion €1.4bn to €1.5bn Ø EBITDA bsi p.
Slide 9: Three levers for success
Three levers for success Portfolio Technology leader with world- scale assets deeply rooted in BASF Verbund Innovation Preferred product partner and leader in chemical process research Sustainability Pioneer for sustainable products with reduced CO2 footprints 8 BASF Capital Markets Day, September 2
Slide 10: Clear portfolio focus to drive financial performance
Portfolio Clear portfolio focus to drive financial performance Market attractiveness Biopharma Pharma Grow Ingredients Excipients Aroma Bioenergy Ingredients Nutrition & Health Vitamin A + E, Enzymes Carotenoids Nutrition Aroma Personal Enzymes Care Pharma Care Chemicals Home Personal Care1 Industri
Slide 11: Zhanjiang Verbund site – driving growth for Nutrition & Care
Portfolio Zhanjiang Verbund site – Expanding our local driving growth for Nutrition & Care presence in fast-growing Asian market Investments in citral and nonionic surfactants (NIS) Global capacity increase Citral: +40kt p.a. NIS: +215kt p.a. Startup in 2025/2026 10 BASF Capital Markets Day, Septemb
Slide 12: Process innovation is key to competitiveness and improved quality in core value chains
Innovation Process innovation is key to competitiveness and improved quality in core value chains Example: Production yield improvements by incremental process innovation for the broad-spectrum UV filter Tinosorb® S Production capacity increase +8% +18% 2017 2020 2023 Production plant in Kaohsiung
Slide 13: Pioneering bio-based solutions to avoid microplastics and synthetic polymers
Innovation Pioneering bio-based solutions to avoid microplastics and synthetic polymers in personal care products BASF’s natural-based, biodegradable wax Sales growth dispersions replace synthetic polymers and potential beyond 2025: silicones in shampoos and shower products 5% – 10% We combine deep
Slide 14: We support our customers in achieving their sustainability targets
Sustainability We support our customers in achieving their sustainability targets by providing products with reduced CO2 footprints Example: Trilon® M Max BioBased versus sodium citrate Example: Synthetic versus natural menthol as chelating agents in automatic dishwasher tablets PCF, excluding bioge
Slide 15: Our strategic priorities will drive BASF value creation 2024 – 2028
Our strategic priorities will drive BASF value creation 2024 – 2028 Drive volume 1 Sharpen portfolio 2 Advancing 3 Drive cost 4 growth and capital operational efficiencies discipline excellence From existing assets Divestments focusing on Asset effectiveness as key Reduction of variable cost via (e.
Slide 16: We will significantly increase earnings by 2028
We will significantly increase earnings by 2028 by growing volumes, productivity gains and streamlining the portfolio 1 Drive volume growth Optimizing existing capacities and fast utilization of new assets ~+150% 2 Focus portfolio for higher returns Targeted EBITDA bsi increase of Allocating funds t
Slide 17: We create chemistry
O- BASF We create chemistry